Patliputra Pharmaceutical & Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 18-12-2024
- Paid Up Capital ₹ 1.50 M
as on 18-12-2024
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 1.49 Cr
as on 18-12-2024
About Patliputra Pharmaceutical & Healthcare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹1.49 Cr.
Pervez Ahmad, Jamshida Praveen, Suraj Prakash, and Three other members serve as directors at the Company.
- CIN/LLPIN
U85300BR2020PTC048477
- Company No.
048477
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Oct 2020
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Company Details
- Location
Patna, Bihar, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Patliputra Pharmaceutical & Healthcare?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pervez Ahmad  | Director | 07-Oct-2020 | Current |
| Jamshida Praveen | Director | 07-Oct-2020 | Current |
| Suraj Prakash | Director | 15-Feb-2023 | Current |
| Rohit Ranjan | Director | 15-Feb-2023 | Current |
| Rakesh Kumar | Director | 15-Feb-2023 | Current |
| Faizur Rahman | Director | 17-Feb-2024 | Current |
Financial Performance of Patliputra Pharmaceutical & Healthcare.
Patliputra Pharmaceutical & Healthcare Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Patliputra Pharmaceutical & Healthcare?
Unlock access to Patliputra Pharmaceutical & Healthcare's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Pharmacraft Private LimitedActive 3 years 7 months
Pervez Ahmad and Jamshida Praveen are mutual person
- Hari Foodgrains Private LimitedActive 3 years 1 month
Suraj Prakash and Rohit Ranjan are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Sep 2022 | ₹1.49 Cr | Open |
How Many Employees Work at Patliputra Pharmaceutical & Healthcare?
Unlock and access historical data on people associated with Patliputra Pharmaceutical & Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Patliputra Pharmaceutical & Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Patliputra Pharmaceutical & Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
